Shares of Biodexa Pharmaceuticals skyrocketed nearly 50% on Monday, hitting their highest level since early December. The ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Biodexa (NASDAQ:BDRX) stock soared 76% in morning trading after the company announced it has received FDA Fast Track designation for its drug eRapa for the treatment of familial adenomatous polyposis, ...

CARDIFF, UK / ACCESS Newswire / February 12, 2025 / Biodexa Pharmaceuticals PLC. (NASDAQ:BDRX), a clinical-stage biopharmaceutical company developing a pipeline of innovative products for the treatmen ...

Biodexa Pharmaceuticals has announced that the US FDA has granted Fast Track designation for its drug eRapa, an encapsulated form of rapamycin, which is being developed for familial adenomatous ...

CARDIFF, UK / ACCESS Newswire / February 12, 2025 / Biodexa Pharmaceuticals PLC. (NASDAQ:BDRX), a clinical-stage biopharmaceutical company developing a pipeline of innovative products for the ...

Here is how argenex SE (ARGX) and Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) have performed compared to their sector so far this year.

Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 4.9%.

Biodexa has previously received Orphan Drug ... In premarket trading Monday, the stock is up by 113.2% at $8.57. The views and opinions expressed herein are the views and opinions of the author ...

16:52 EST Biodexa Pharmaceuticals (BDRX ... and streamline your search for investment opportunities using Tipranks' Stock Screener Published first on TheFly – the ultimate source for real ...

it received a Staff Determination letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Ma July 23, 2024 Biodexa Pharmaceuticals PLC Announces Closing of $5.0 Million ...